Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

OBJECTIVES: The purpose of this study was to investigate the effects of mineralocorticoid receptor antagonists (MRAs) on systolic blood pressure (SBP) and outcomes according to baseline SBP in patients with heart failure with reduced ejection fraction (HFrEF). BACKGROUND: MRAs are greatly underused...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JACC Heart Fail
Autors principals: Serenelli, Matteo, Jackson, Alice, Dewan, Pooja, Jhund, Pardeep S., Petrie, Mark C., Rossignol, Patrick, Campo, Gianluca, Pitt, Bertram, Zannad, Faiez, Ferreira, João Pedro, McMurray, John J.V.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7086149/
https://ncbi.nlm.nih.gov/pubmed/31926854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2019.09.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars